Evidence map›Paper›PMID 41136980›Full record

ArticleBMC cancer2025

OPTILATER: optimal long-term survival after cancer - a cross-sectional study protocol for a quantitative survey on the care situation of long-term cancer survivors in Germany.

C N Martin, N De Lazzari, J Kersten, K Claassen, C Jansen, K Kaminski, F Baumann, M Götte, S Palm, A Stang and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. [The North Rhine-Westphalia State Cancer Registry-a historical review from 1974-2025].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

C N MartinClinic for Psychosomatic Medicine und Psychotherapy, LVR-University Hospital Essen, Essen, North Rhine-Westphalia, Germany. carl.martin@lvr.de.
N De LazzariDepartment of Palliative Medicine, University Hospital Essen, West German Cancer Center Essen, Essen, North Rhine-Westphalia, Germany.
J KerstenDeparment I of Internal Medicine, Center of Integrated Oncology, University Hospital Cologne, Cologne, North Rhine-Westphalia, Germany.
K ClaassenCancer Registry of North-Rhine Westphalia, Bochum, North Rhine-Westphalia, Germany.
C JansenClinic for Psychosomatic Medicine und Psychotherapy, LVR-University Hospital Essen, Essen, North Rhine-Westphalia, Germany.
K KaminskiUniversity Hospital Essen, West German Cancer Center Essen, Registry, Essen, North Rhine-Westphalia, Germany.
F BaumannDeparment I of Internal Medicine, Center of Integrated Oncology, University Hospital Cologne, Cologne, North Rhine-Westphalia, Germany.
M GötteUniversity Hospital Essen, West German Cancer Center Essen, Board of Directors, Essen, North Rhine-Westphalia, Germany.
S PalmUniversity Hospital Essen, West German Cancer Center Essen, Registry, Essen, North Rhine-Westphalia, Germany.
A StangInstitute of Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Essen, North Rhine-Westphalia, Germany.
V GrünwaldDepartment of Urology, University Hospital Essen, Essen, North Rhine- Westphalia, Germany.
U DirksenUniversity Hospital Essen, West German Cancer Center Essen, Board of Directors, Essen, North Rhine-Westphalia, Germany.
M A TeufelClinic for Psychosomatic Medicine und Psychotherapy, LVR-University Hospital Essen, Essen, North Rhine-Westphalia, Germany.
E-M SkodaClinic for Psychosomatic Medicine und Psychotherapy, LVR-University Hospital Essen, Essen, North Rhine-Westphalia, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCancer survivors in Germany face considerable challenges related to the late and long-term effects of treatment and a lack of post-treatment support. Despite an increasing number of cancer survivors, existing healthcare systems are insufficiently adapted to meet their ongoing needs, particularly for long-term survivors who may experience physical, emotional, and socio-economic hardships. This study aims to address the knowledge gaps in the care situation of long-term cancer survivors, focusing on their experiences and the barriers they face in accessing care.

methodsThis study protocol outlines the methodology for a quantitative survey involving up to 3,300 long-term cancer survivors across various cancer types in Germany. The survey assesses their experiences with cancer care, focusing on diet, exercise, mental health, sleep, cognition, overall health-related quality of life, and somatic late effects. Special attention is given to survivors from diverse socio-demographic backgrounds, including those with a migration history, in order to explore the unique challenges they face. DISCUSSION: The results of the study will contribute to the development of needs-based care recommendations for cancer survivors, particularly those in potentially vulnerable groups. The findings will inform the design of more inclusive care strategies and interventions, leading to better long-term health outcomes for cancer survivors in Germany.

trial registrationGerman Clinical Trials Register: DRKS00032146, registered on 03/12/2024.

Indexed as

Cancer SurvivorsNeoplasmsCross-Sectional StudiesFemaleGermanyHumansMaleMiddle AgedQuality of LifeSurveys and QuestionnairesCancer care barriersCancer survivorsGermanyHealth-related quality of lifeLong-term careMigration backgroundNeeds-based careQuantitative interviewsSomatic late effectsSurvivorship care

Identifiers

PMID41136980
PMCPMC12553282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.